Clinical Research Studies

The purpose of this study is to test if a single dose of nerinetide can reduce neurological disability in people who have had a stroke and who are selected for endovascular therapy. Nerinetide is an investigational drug being developed as an emergency medication aimed at preventing damage to brain cells during a stroke. “Investigational” means that the drug is being tested in a research study and is not approved by the U.S. Food and Drug Administration (FDA) to treat your condition. Nerinetide acts by blocking a protein in the brain responsible for cell damage during a stroke. The safety of nerinetide has been tested previously in healthy people and in patients having strokes.